(NASDAQ: NVCR) Novocure's forecast annual revenue growth rate of 8% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.
Novocure's revenue in 2024 is $525,659,000.On average, 5 Wall Street analysts forecast NVCR's revenue for 2024 to be $59,184,155,351, with the lowest NVCR revenue forecast at $56,948,858,059, and the highest NVCR revenue forecast at $61,015,480,659. On average, 5 Wall Street analysts forecast NVCR's revenue for 2025 to be $63,556,178,187, with the lowest NVCR revenue forecast at $61,558,916,598, and the highest NVCR revenue forecast at $66,342,228,971.
In 2026, NVCR is forecast to generate $72,084,571,261 in revenue, with the lowest revenue forecast at $67,030,939,863 and the highest revenue forecast at $77,179,740,535.